Stay updated on Brexanolone Safety in Adolescent PPD Clinical Trial
Sign up to get notified when there's something new on the Brexanolone Safety in Adolescent PPD Clinical Trial page.

Latest updates to the Brexanolone Safety in Adolescent PPD Clinical Trial page
- Check5 days agoChange DetectedThe footer revision identifier changes from v3.7.1 to v3.7.2 on the 403 Forbidden page.SummaryDifference0.2%

- Check12 days agoChange DetectedThe footer identifies the ClinicalTrials.gov site revision as v3.7.1 instead of v3.7.0.SummaryDifference0.2%

- Check19 days agoNo Change Detected
- Check32 days agoChange DetectedThe study record page for NCT03665038 now shows a 403 Forbidden error, replacing the expected study details with an access-block message.SummaryDifference17%

- Check54 days agoChange DetectedThe page revision tag was updated from v3.6.5 to v3.6.6. A new addition notes a 2017 NIH grant/contract, indicating added funding information.SummaryDifference0.1%

- Check68 days agoChange DetectedAn error page was replaced with a complete study record, adding Related Info, sponsor details, helpful links, and key documents (Study Protocol, Statistical Analysis Plan) along with IPD sharing information; the update expands the study metadata and locations, improving access to the full trial record.SummaryDifference52%

- Check75 days agoChange DetectedRevision tag updated from v3.6.4 to v3.6.5. This indicates a minor update to the study documentation or page framework rather than substantive content changes.SummaryDifference0.0%

Stay in the know with updates to Brexanolone Safety in Adolescent PPD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Brexanolone Safety in Adolescent PPD Clinical Trial page.